Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in AVXL — Anavex Life Sciences Corp.

CIK 1423053 MIAMI, FL
Back to AVXL Full portfolio

Position in AVXL

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$852,407
-$865,057 QoQ
Shares Held
329,115
-41.2% QoQ
Ownership
0.355%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 179 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVXL Over Time

Shares Held

Position Value (USD)

Derivatives in AVXL

reported options exposure · as of Jun 30, 2026
CallValue
$560,217
CallShares
216,300
PutValue
$263,403
PutShares
101,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,758,606 across 435 Biotechnology names. AVXL ranks #238 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in AVXL

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $852,407 329,115
2026-06-30 $263,403 101,700
2026-06-30 $560,217 216,300
2026-03-31 $1,717,464 559,435
2026-03-31 $181,744 59,200
2026-03-31 $1,698,938 553,400
2025-12-31 $2,517,988 707,300
2025-12-31 $790,676 222,100
2025-12-31 $404,909 113,739
2025-09-30 $3,480,790 391,100
2025-09-30 $716,450 80,500
2025-09-30 $1,741,952 195,725
2025-06-30 $299,650 32,500
2025-06-30 $2,714,368 294,400
2025-06-30 $2,970,730 322,205
2025-03-31 $322,608 37,600
2025-03-31 $4,066 474
2025-03-31 $2,741,310 319,500
2024-12-31 $592,848 55,200
2024-12-31 $2,587,330 240,906
2024-12-31 $4,000,650 372,500
2024-09-30 $1,515,992 266,900
2024-09-30 $339,664 59,800
2024-09-30 $144,981 25,525
2024-06-30 $1,885,655 446,838
2024-06-30 $161,204 38,200
2024-06-30 $1,002,250 237,500
2024-03-31 $20 4
2024-03-31 $233,122 45,800
2024-03-31 $1,878,719 369,100
2023-12-31 $2,544,515 273,310
2023-12-31 $2,623,558 281,800
2023-12-31 $1,316,434 141,400
2023-09-30 $1,114,810 170,200
2023-09-30 $3,766,950 575,107
2023-09-30 $830,540 126,800
2023-06-30 $977,226 120,200
2023-06-30 $354,939 43,658
2023-06-30 $1,403,238 172,600
2023-03-31 $3,824,791 446,300
2023-03-31 $10,781 1,258
2023-03-31 $421,644 49,200
2022-12-31 $1,658,466 179,100
2022-12-31 $3,887,348 419,800
2022-12-31 $1,787,541 193,039
2022-09-30 $2,069,160 200,500
2022-09-30 $4,828,789 467,906
2022-09-30 $1,222,920 118,500
2022-06-30 $1,339,338 133,800
2022-06-30 $7,004,186 699,719